Dr. Edwin Glass, M.D.
What this data tells you about Dr. Glass
Dr. Edwin Glass is a nuclear medicine specialist in Santa Monica, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Glass performed 622 Medicare services across 616 unique beneficiaries.
Between the years covered by Open Payments, Dr. Glass received a total of $114 from 3 pharmaceutical and/or device companies across 4 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Glass is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
346 | $44 | $633 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 54 | $281 | $1,300 |
| Technetium Tc-99m medronate diagnostic injection An injection of Technetium Tc-99m medronate used for diagnostic imaging studies. The dose administered is up to 30 millicuries per study. |
48 | $11 | $450 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
42 | $4 | $24 |
| Brain nuclear medicine study with metabolic evaluation A nuclear medicine imaging test that uses radioactive tracers to evaluate brain metabolism. This procedure helps assess how brain tissues are functioning at a metabolic level. |
33 | $1,441 | $7,500 |
| SPECT/CT scan, single area A nuclear medicine imaging study that combines single-photon emission computed tomography (SPECT) with a concurrent CT scan to create detailed images of a single body area. |
26 | $408 | $2,400 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
19 | $1,406 | $7,500 |
| SPECT/CT nuclear medicine scan, multiple areas A combined nuclear medicine and CT imaging study performed on at least two body areas or through separate acquisitions on the same day. |
15 | $783 | $4,400 |
| Technetium Tc-99m sulfur colloid diagnostic injection A diagnostic injection of Technetium Tc-99m sulfur colloid used for imaging studies. The dose administered is up to 20 millicuries per study. |
14 | $239 | $1,224 |
| Lymphatic system nuclear medicine study A nuclear medicine imaging test used to evaluate the structure and function of the lymphatic system. |
13 | $291 | $950 |
| CT scan of heart blood vessels and grafts with contrast A CT scan that uses contrast dye to create detailed images of the heart's blood vessels and any surgical grafts. |
12 | $252 | $975 |
Industry Payment Transparency
Open Payments through 2023 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2023)
All-time payments by company (2018-2023) ›
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
1.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Glass is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Glass experienced with bone density scan (dexa)?
Does Dr. Glass receive payments from pharmaceutical companies?
How do Dr. Glass's costs compare to other nuclear medicines in Santa Monica?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology